ACTIVE SUBSTANCE / INN

LISDEXAMFETAMINE DIMESYLATE

Brand name(s): VYVANSE, ARYNTA, LISDEXAMFETAMINE DIMESYLATE
FDA LISTED
PRESCRIPTION
ANDA211840
NDA208510
ACTIVE SUBSTANCE
Lisdexamfetamine Dimesylate
REGULATORS
FDA
SPONSORS / MAH
TAKEDA PHARMS USA, AZURITY, SPECGX LLC
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LISDEXAMFETAMINE DIMESYLATEANDA211840SPECGX LLCPrescription
ARYNTANDA219847AZURITYPrescription
VYVANSENDA208510TAKEDA PHARMS USAPrescription

FULL INTELLIGENCE ON LISDEXAMFETAMINE DIMESYLATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →